ANVISA · RDC 243/2018 · IN 28/2018

Mark it compliant.
Market confidently.

Instant ANVISA regulatory screening against the IN 28/2018 positive list. Built for brands entering the Brazilian market.

Full positive list (IN 28/2018)
Single ingredient or full formula screening
Dose vs ANVISA limit calculations
Region

Try an example

MARCO BR is for screening purposes only. Not legal or regulatory advice. Verify all findings with ANVISA and a qualified regulatory consultant before any commercialization decision.